GeneHealth - Your precision medicine

Diabetic Neuropathy

Disease Details

Family Health Simplified

Buy Membership

Description: Diabetic neuropathy is a type of nerve damage that can occur in people with diabetes, leading to pain, numbness, and weakness, primarily in the hands and feet.
Type: Diabetic neuropathy is a type of peripheral neuropathy. It is not typically associated with genetic transmission; rather, it is primarily caused by prolonged high blood sugar levels associated with diabetes.
Signs And Symptoms: Diabetic neuropathy can affect any peripheral nerves including sensory neurons, motor neurons, and the autonomic nervous system. Therefore, diabetic neuropathy has the potential to affect essentially any organ system and can cause a range of symptoms. There are several distinct syndromes based on the organ systems affected.
Prognosis: The mechanisms of diabetic neuropathy are poorly understood. At present, treatment alleviates pain and can control some associated symptoms, but the process is generally progressive.
As a complication, there is an increased risk of injury to the feet because of loss of sensation (see diabetic foot). Small infections can progress to ulceration and this may require amputation.
Onset: Diabetic neuropathy typically develops gradually over time. The onset can occur after a prolonged period of poorly controlled blood sugar levels. Symptoms often begin in the extremities, such as the feet and hands, and may include numbness, tingling, pain, or weakness. Managing blood sugar is crucial to prevent or slow the progression of diabetic neuropathy.
Prevalence: Diabetic neuropathy is a common complication of diabetes, affecting approximately 50% of individuals with diabetes during their lifetime. This condition is characterized by nerve damage, often leading to pain, numbness, and weakness, primarily in the extremities.
Epidemiology: Globally diabetic neuropathy affects approximately 132 million people as of 2010 (1.9% of the population).Diabetes is the leading known cause of neuropathy in developed countries, and neuropathy is the most common complication and greatest source of morbidity and mortality in diabetes. It is estimated that neuropathy affects 25% of people with diabetes. Diabetic neuropathy is implicated in 50–75% of nontraumatic amputations.
The main risk factor for diabetic neuropathy is hyperglycemia. In the DCCT (Diabetes Control and Complications Trial, 1995) study, the annual incidence of neuropathy was 2% per year but dropped to 0.56% with intensive treatment of Type 1 diabetics. The progression of neuropathy is dependent on the degree of glycemic control in both Type 1 and Type 2 diabetes. Duration of diabetes, age, cigarette smoking, hypertension, height, and hyperlipidemia are also risk factors for diabetic neuropathy.
Intractability: Diabetic neuropathy is often considered intractable because there is currently no cure. However, symptoms can be managed with treatments that aim to control blood sugar levels, relieve pain, and manage complications. Effective management may reduce the progression and severity of symptoms, but complete reversal of nerve damage is generally not achievable.
Disease Severity: Diabetic neuropathy is a type of nerve damage that can occur if you have diabetes. The severity can vary significantly among individuals. It ranges from mild symptoms, such as tingling or numbness, to severe symptoms, including debilitating pain, loss of sensation, and problems with digestion, urination, and cardiovascular issues. In extreme cases, it can lead to infections and amputations due to unnoticed injuries. Regular monitoring and optimal blood sugar control are essential to manage and mitigate the severity.
Healthcare Professionals: Disease Ontology ID - DOID:9743
Pathophysiology: Diabetic neuropathy is a type of nerve damage that can occur with diabetes. The pathophysiology involves several mechanisms:

1. **Hyperglycemia**: High blood sugar levels can damage nerves over time through various pathways, including the polyol pathway, which increases sorbitol and fructose in nerves, leading to osmotic stress.

2. **Oxidative Stress**: Chronic hyperglycemia increases the production of reactive oxygen species (ROS), causing oxidative stress and inflammation, which further damages nerve cells and blood vessels supplying the nerves.

3. **Microvascular Damage**: Damage to small blood vessels (microangiopathy) reduces blood flow to the nerves, depriving them of essential nutrients and oxygen, which can lead to nerve degeneration.

4. **Advanced Glycation End Products (AGEs)**: High blood sugar levels promote the formation of AGEs, which can interfere with normal cell function and promote inflammation and nerve damage.

5. **Inflammatory Pathways**: Chronic inflammation associated with diabetes can contribute to nerve injury by activating immune cells that release pro-inflammatory cytokines.

These processes collectively contribute to the structural and functional damage observed in diabetic neuropathy, resulting in symptoms like pain, tingling, numbness, and weakness, primarily in the feet and hands.
Carrier Status: Diabetic neuropathy is a type of nerve damage that can occur with diabetes. It is not a condition associated with carrier status, as it is not a genetic disorder transmissible from parent to offspring. Instead, it typically results from prolonged high blood sugar levels leading to nerve damage.
Mechanism: Diabetic neuropathy is a type of nerve damage that can occur in people with diabetes. The primary mechanism involves prolonged exposure to high blood glucose levels, which leads to various pathological changes in the nerves.

**Molecular mechanisms:**

1. **Polyol Pathway Hyperactivity**: Increased glucose levels are shunted to the polyol pathway, converting glucose to sorbitol through the enzyme aldose reductase. Accumulation of sorbitol and fructose can lead to osmotic stress and neuronal damage.

2. **Advanced Glycation End-products (AGEs)**: High blood sugar induces the formation of AGEs, which can alter protein function and structure. AGEs interact with their receptors (RAGE), triggering inflammation and oxidative stress, damaging nerve cells.

3. **Oxidative Stress**: Hyperglycemia increases the production of reactive oxygen species (ROS) and decreases antioxidant defenses, leading to oxidative stress, which damages cellular components, including DNA, proteins, and lipids in nerve cells.

4. **Protein Kinase C (PKC) Activation**: Elevated glucose levels activate PKC, leading to changes in blood flow, increased vascular permeability, and inflammation. These changes can impair nerve blood supply and contribute to nerve damage.

5. **Mitochondrial Dysfunction**: Hyperglycemia can impair mitochondrial function, leading to decreased ATP production and increased production of ROS, contributing to neurodegeneration.

6. **Inflammation**: Chronic high blood sugar levels can cause low-grade inflammation, involving various inflammatory cytokines (e.g., TNF-α, IL-6), which can damage nerve tissues.

These molecular mechanisms collectively contribute to nerve damage, impaired nerve signaling, and the symptoms associated with diabetic neuropathy.
Treatment: The treatment for diabetic neuropathy focuses on managing pain, slowing the progression of the disease, and addressing complications.

1. **Blood Sugar Control**: Tight blood sugar control is key to preventing further nerve damage.
2. **Medications for Pain Relief**:
- Anticonvulsants such as pregabalin and gabapentin.
- Antidepressants like duloxetine and amitriptyline.
- Pain relievers, including topical treatments like capsaicin.
3. **Lifestyle and Home Remedies**:
- Regular physical activity.
- Balanced diet rich in vitamins and low in sugar.
- Avoiding smoking and alcohol.
4. **Foot Care**: Regular foot inspection and proper footwear to prevent injuries.
5. **Complementary Therapies**: Acupuncture, biofeedback, and physical therapy can provide pain relief.
6. **Managing Complications**: Addressing issues such as digestive problems or urinary tract infections promptly.
Compassionate Use Treatment: For diabetic neuropathy, compassionate use treatments and off-label or experimental treatments may include:

1. **Alpha-lipoic acid**: This antioxidant has shown promise in reducing neuropathic pain and improving nerve function in some studies.

2. **Capsaicin patches**: Typically used for pain relief, capsaicin patches may provide some benefit in reducing neuropathic pain when used off-label.

3. **Duloxetine or Pregabalin**: While commonly prescribed for diabetic neuropathy, usage in certain patient populations or specific clinical scenarios may be considered off-label.

4. **Spinal cord stimulation**: This is an experimental method where electrical impulses are used to block pain signals from reaching the brain.

5. **Stem cell therapy**: Still in the experimental phase, this treatment aims to repair or regenerate damaged nerves.

6. **Gene therapy**: Investigational approaches are exploring the modification of genes to alleviate symptoms or address underlying causes of neuropathy.

Consultation with a healthcare provider is critical to determine the appropriateness and potential risks of these treatments.
Lifestyle Recommendations: Lifestyle recommendations for managing diabetic neuropathy typically include:

1. Blood Sugar Control: Maintain optimal blood glucose levels as per your healthcare provider's advice.
2. Healthy Diet: Focus on a balanced diet rich in vegetables, fruits, whole grains, and lean proteins. Limit sugar and saturated fats.
3. Regular Exercise: Engage in physical activities like walking, swimming, or stationary cycling to improve blood flow and maintain a healthy weight.
4. Smoking Cessation: Quit smoking to enhance circulation and reduce nerve damage risks.
5. Foot Care: Inspect your feet daily for blisters, cuts, or sores. Keep feet clean and moisturized, and wear comfortable, well-fitting shoes.
6. Avoid Alcohol: Limit alcohol intake to avoid further nerve damage.
7. Stress Management: Practice relaxation techniques such as yoga, meditation, or deep-breathing exercises to manage stress.
8. Regular Check-ups: Have regular appointments with your healthcare provider to monitor and manage your condition effectively.

Consult with a healthcare professional for personalized advice.
Medication: Medication options for pain control include antiepileptic drugs (AEDs), serotonin-norepinephrine reuptake inhibitors (SNRIs), and tricyclic antidepressants (TCAs).A systematic review concluded that "tricyclic antidepressants and traditional anticonvulsants are better for short term pain relief than newer generation anticonvulsants." A further analysis of previous studies showed that the agents carbamazepine, venlafaxine, duloxetine, and amitriptyline were more effective than placebo, but that comparative effectiveness between each agent is unclear.The only three medications approved by the United States' Food and Drug Administration for diabetic peripheral neuropathy (DPN) are the antidepressant duloxetine, the anticonvulsant pregabalin, and the long-acting opioid tapentadol ER (extended release). Before trying a systemic medication, some doctors recommend treating localized diabetic peripheral neuropathy with lidocaine patches.
Repurposable Drugs: Repurposable drugs for diabetic neuropathy include certain anticonvulsants like gabapentin and pregabalin, antidepressants like duloxetine and amitriptyline, and analgesics such as capsaicin and topical lidocaine. These medications were originally developed for other conditions but have been found to alleviate neuropathic pain associated with diabetes.
Metabolites: Diabetic neuropathy is a type of nerve damage resulting from diabetes. Key metabolites involved in diabetic neuropathy include glucose and advanced glycation end-products (AGEs). Elevated levels of glucose can lead to the formation of AGEs, which contribute to oxidative stress and inflammation, damaging the nerves. Nanotechnology approaches, such as the use of nanoparticles, are being explored to improve the delivery of drugs and therapeutic agents targeting the underlying mechanisms of diabetic neuropathy.
Nutraceuticals: Nutraceuticals for diabetic neuropathy can potentially include:

1. **Alpha-Lipoic Acid (ALA):** An antioxidant that has been shown to reduce symptoms of diabetic neuropathy, such as pain and tingling.

2. **Acetyl-L-Carnitine:** May improve nerve function and reduce pain in people with diabetic neuropathy.

3. **Vitamin B12 (Methylcobalamin):** Essential for nerve health; deficiency can exacerbate neuropathy symptoms.

4. **Omega-3 Fatty Acids:** Found in fish oil; may help reduce inflammation and improve nerve health.

5. **Curcumin:** The active compound in turmeric; has anti-inflammatory and antioxidant properties that may benefit diabetic neuropathy.

6. **Gamma-Linolenic Acid (GLA):** Found in evening primrose oil; may improve nerve function and reduce symptoms.

Please consult with a healthcare provider before starting any new nutraceutical regimen.
Peptides: For diabetic neuropathy, research into peptide-based therapies and nanotechnology-based approaches is ongoing. Peptides, such as those that mimic nerve growth factors, may help in promoting nerve repair and reducing pain. Nanotechnology, including the use of nanoparticles for drug delivery, holds potential for targeted treatment, improving the efficacy and reducing the side effects of therapy for diabetic neuropathy. These innovative approaches are still largely in the experimental stages, but they offer promising avenues for future treatments.